missing translation for 'onlineSavingsMsg'
Learn More

CCG-1423, MedChemExpress

Product Code. 16446386
Encompass_Preferred
Click to view available options
Quantity:
10 mg
50 mg
100 mg
200 mg
Unit Size:
100mg
10mg
200mg
50mg
This item is not returnable. View return policy

Product Code. 16446386

Brand: Medchem Express HY13991

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis.

CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis.

Specifications

Chemical Name or Material CCG-1423
Physical Form Solid
CAS 285986-88-1
Color White
Quantity 100 mg
Purity Grade Notes Research
Molecular Formula C18H13ClF6N2O3
For Use With (Application) Cancer-Kinase/protease
Solubility Information DMSO : ≥ 26 mg/mL (57.17 mM)
SMILES O=C(NOC(C)C(NC1=CC=C(Cl)C=C1)=O)C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2
Molecular Weight (g/mol) 454.75
Formula Weight 454.75
Percent Purity 99.9%
Grade Research
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.